| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Aranda Richard serves as a Chief Medical Officer at GOSS. Across recent SEC filings that breaks down to 0 buys and 8 sells.
Historically, Aranda Richard's trades have earned a middling insider score of 66/100 across 8 rated trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +26.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 1,908 | $0.66 | $1,260.23 | -1.0% | +21.1% | +67.0% | |
| Mar 18, 2024 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 4,018 | $1.33 | $5,341.93 | -2.0% | -62.3% | +2.9% | |
| Jun 22, 2023 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 1,814 | $1.29 | $2,340.06 | -0.9% | -34.2% | -51.9% | |
| Mar 16, 2023 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 7,563 | $1.10 | $8,304.17 | -3.7% | +19.0% | +39.0% | |
| Oct 24, 2022 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 4,757 | $12.07 | $57,431.26 | -2.3% | -82.6% | -96.0% | |
| Jun 22, 2022 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 1,778 | $6.88 | $12,232.64 | -0.8% | +87.1% | -81.4% | |
| Mar 16, 2022 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 6,278 | $8.28 | $51,975.56 | -2.9% | -30.5% | -87.8% | |
| Oct 25, 2021 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sell | 2,377 | $12.25 | $29,118.25 | -1.1% | -19.3% | -6.2% |